Determination of LNP Composition and Lipid Ratios
After developing an initial formulation matrix by mixing different lipids in varying ratios, utilize analytical techniques such as dynamic light scattering (DLS), 2-(p-toluidinyl)naphthalene-6-sulphonic acid (TNS) ionization assays and plate-based high-content screening to assess the characteristics of the lipid nanoparticles (LNPs). Observe how changes in these lipid ratios influence these parameters.
Phenomenex Biozen Columns enable analytical quality by design to ensure high-quality data when determining LNP compositions and ratios. The SCIEX ZenoTOF 7600+ system provides deep insights into the structure of lipids, including lipid impurities, with excellent quantitative performance for data-driven decision-making.
Robust data management, automated data analysis and integration of results across multiple assays are needed in assessing and determining the best LNP formulations. Genedata and IDBS provide scalable, enterprise-level cloud software products from R&D through manufacturing for assured confidence in both GxP and non-GxP environments.
Out-of-the-box, the Genedata Biopharma Platform enables accurate LC/MS-based quantitation of relative abundance ratios in complex samples, accelerating large-scale high-throughput analyses. Genedata also automates and centralizes the analysis of multiple plate-based assays during mRNA-LNP development, such as dynamic light scattering (DLS), TNS ionization assays, RiboGreen mRNA encapsulation assays, toxicity, cell trafficking and automated ELISAs. The platform captures process information, mRNA cargo, LNP components, and lipid ratios, as well as raw materials, and integrates all assay results for faster decision-making. The Genedata Biopharma Platform provides cutting-edge support for in silico determination of ideal LNP composition and lipid ratios.
Capabilities within IDBS Polar software allow scientists to design, execute and analyze experiments within a single platform to understand material genealogy, process performance and determine which parameters are most influential based on statistical analysis. This allows scientists to improve reproducibility to reduce the number of experiments that are needed to gain process understanding, optimize product quality and support regulatory compliance.
Determination of LNP Composition and Lipid Ratios Products
ZenoTOF 7600 System for Mass Spectrometry
A high-resolution mass spectrometry solution that combines powerful MS/MS sensitivity, fragmentation technology and a step-change in data independent acquisition.
View ProductsBiozen LC Columns
From mAbs to Oligos, We Have You Covered Phenomenex is committed to the development of novel chromatographic solutions that advance biopharmaceutical development. This rapidly-growing industry necessitates fit for purpose applications and innovative technologies to meet the expanding analytical challenges of the field. Phenomenex columns and sample preparation solutions are designed to tackle the multi-faceted analytical needs of large molecule analysis, particularly in the area of biopharmaceutical analysis. Leveraging cutting-edge technology and expertise, our biopharmaceutical solutions provide tailored support for accurate and reliable results in this specialized field.
View ProductsGenedata Biopharma Platform: Biopharma Automation & AI
Genedata transforms biopharma R&D through automation, advanced analytics, and AI. As the first biologics-native technology company, we lead digitalization and enable data-driven decision-making for biopharma organizations worldwide. The Genedata Biopharma Platform combines a unified data model with workflow automation and embedded AI to accelerate and optimize end-to-end discovery and development of biologics and other modalities.
View ProductsIDBS Polar
An enterprise lab informatics software platform with ELN, LES and LIMS capabilities designed to power scientific innovation.
View Products